Darifenacin 62332-0223-30

Package NDC

62332-0223-30

Manufacturer: Alembic Pharmaceuticals Inc.
Dosage Form: Tablet, Extended Release
Route: Oral
Product Type: Human Prescription Drug
Marketing Start: December 12, 2017
Listing Expires: December 31, 2026
Application: ANDA207681

Need to source Darifenacin? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Darifenacin Hydrobromide	7.5 mg/1

Drug Class

Cholinergic Muscarinic Antagonist [EPC]Cholinergic Muscarinic Antagonists [MoA]

Selected Package

62332-0223-30Selected

30 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-223-30)

Other packages for this product(3)

62332-0223-08

8 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (62332-223-08)

View →

62332-0223-90

90 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-223-90)

View →

62332-0223-91

1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-223-91)

View →